Prevalence of abnormal urinary albumin excretion in a population-based study in Spain: Results from the HERMEX Study

European Journal of Clinical Investigation

Volumn 42, Issue 12, 2012, Pages 1272-1277

  Robles, Nicolas R ^a   Felix, Francisco J ^b   Fernandez Berges, Daniel ^c,d,e   Perez Castán, Jose F ^d   Zaro, Maria J ^e   Lozano, Luis ^f   Alvarez Palacios, Paula ^c   Garcia Trigo, Antonio ^c   Tejero, Veronica ^c   Morcillo, Yolanda ^c   Hidalgo, Ana B ^c  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b Centro de Salud Villanueva de la Serena Norte   (Spain)

^c Programa de Investigación en Enfermedades Cardiovasculares   (Spain)

^d Gerencia de Area de Don Benito Villanueva de la Serena   (Spain)

^e HOSPITAL DON BENITO VILLANUEVA   (Spain)

^f Centro de Salud Merida   (Spain)

Author keywords

Cardiovascular risk; Cardiovascular risk factors; Microalbuminuria

Indexed keywords

ALBUMIN; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORBIDITY; OBESITY; OBSERVATIONAL STUDY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; PULSE PRESSURE; SEX DIFFERENCE; SPAIN; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS;

ADULT; AGED; ALBUMINURIA; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PREVALENCE; RISK FACTORS; SPAIN;

EID: 84869887458     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2012.02726.x     Document Type: Article

References (38)

1. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetics. N Engl J Med 1984;310:66.
2. Haffner SM, Stein MB, Gruber KK, Hazuda HP, Mitchell BD, Patterson JK. Microalbuminuria: potential marker for increased cardiovascular risk factors in non-diabetic subjects? Arteriosclerosi 1990;10:727-31.
3. Mann JFE, Gerstein HE, Yi QL, Loon EM, Hoogwerf BJ, Rashkow A et al. Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study. J Am Soc Nephrol 2003;14:641-7.
4. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-87.
5. de Pablos-Velasco PL, Martinez-Martin FJ, Aguilar JA. Prevalence of hypertension in IDDM patients in the northern Grand Canary Island, according to the WHO/ISH and JNC-V/ADA criteria. Diabetes Res Clin Pract 1997;38:191-7.
6. Campos-Pastor MM, Escobar-Jimenez F, Mezquita P, Herrera-Pombo JL, Hawkins-Carranza F, Luna JD et al. Factors associated with microalbuminuria in type 1 diabetes mellitus: a cross-sectional study. Diabetes Res Clin Pract 2000;48:43-9.
7. Cantón A, Fernández Castańer M, Conget I, Carreras G, Castell C, Tresserras R. Type 1 diabetes mellitus in Catalonia: chronic complications and metabolic control ten years after onset. Med Sci Monit 2004;10:CR185-90.
8. Gonzalez-Clemente JM. Diabetes mellitus no dependiente de insulina: asistencia en un área de Barcelona. Med Clin (Barc) 1997 25; 108:91-97.
9. Gonzalez-Clemente JM, Esmatjes E, Navarro P, Ercilla G, Casamitjana R, Rios M et al. Microalbuminuria development in short-term IDDM. Diabetes Res Clin Pract 1994;24:15-23.
10. Esmatjes E, Castel C, Goday A, Montanya E, Pou JM, Salinas I et al. Prevalencia de nefropatía en la diabetes mellitus tipo I. Med Clin (Barc) 1998;110:6-10.
11. Esmatjes E, De Alvaro F, 'Estudio Diamante' Investigators. Incidence of diabetic nephropathy in Type 1 diabetic patients in Spain: 'Estudio Diamante'. Diabetes Res Clin Pract 2002;57:35-43.
12. Esmatjes E, Castell C, Gonzalez T, Tresserras R, Lloveras G. Epidemiology of renal involvement in type II diabetics (NIDDM) in Catalonia. The Catalan Diabetic Nephropathy Study Group. Diabetes Res Clin Pract 1996;32:157-63.
13. Relimpio F, Pumar A, Losada F, Molina J, Maynar A, Acosta D et al. Urinary albumin excretion rate and cardiovascular disease in Spaniard type 2 diabetic patients. Diabetes Res Clin Pract 1997;36:127-34.
14. Mur T, Franch J, Morató J, Llovera A, Vilarrubias M, Ros C. Nefropatía y microalbuminuria en la diabetes tipo II. Aten Primaria 1995;16:516-24.
15. Robles NR, Velasco J, Mena C, Angulo E, Garrote T, en representación de los investigadores del estudio MICREX. Microalbuminuria en pacientes diabéticos y en pacientes con hipertensión arterial: estudio de una cohorte de 979 pacientes. Med Clín (Barc) 2006;127:761-4.
16. De la Sierra A, Egocheaga MI, Aguilera MT. Prevalencia y características clínicas de la microalbuminuria en la población española con hipertensión arterial. Med Clin (Barc) 2008;130:201-5.
17. Gonzalez-Juanatey JR, Alegría E, Zamorano J, Bertomeu V, Velasco O, Parrondo I et al. Albuminuria y riesgo cardiovascular. Estudio KORAL-CARDIO. Nefrología 2006;26:426-32.
18. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
19. Bonet J, Vila J, Alsina MJ, Ancochea L, Romero R, en representación del grupo Baetulo. Prevalencia de microalbuminuria en la población general de un área mediterránea española y su asociación con otros factores de riesgo cardiovascular. Med Clin (Barc) 2001;116:573-4.
20. Anon. Plan Integral de enfermedades cardiovasculares de Extremadura. Merida: Junta de Extremadura, 2007.
21. Young BA, Katon WJ, Von Korff M, Simon GE, Lin EH, Ciechanowski PS et al. Racial and ethnic differences in microalbuminuria prevalence in a diabetes population: the pathways study. J Am Soc Nephrol 2005;16:219-28.
22. Redon J, Morales-Olivas F, Galgo A, Brito MA, Mediavilla J, Marin R et al. Urinary albumin excretion and glomerular filtration rate across the spectrum of glucose abnormalities in essential hypertension. J Am Soc Nephrol 2006;17:S236-45.
23. De la Sierra A, Egocheaga MI, Aguilera MT. Prevalencia y características clínicas de la microalbuminuria en la población española con hipertensión arterial. Med Clin (Barc) 2008;130:201-5.
24. Grau M, Elosua R, Cabrera de León A, Guembe MJ, Baena-Díez JM, Vega Alonso T et al. Cardiovascular risk factors in Spain in the first decade of the 21st Century, a pooled analysis with individual data from 11 population-based studies: the DARIOS study. Rev Esp Cardiol 2011;64:295-304.
25. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third national health and nutrition examination survey. Am J Kidney Dis 2003;41:1-12.
26. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage: the steno hypothesis. Diabetologia 1989;32:219-26.
27. Pollock CA, Poronnik P. Albumin transport and processing by the proximal tubule: physiology and pathophysiology. Curr Opin Nephrol Hypertens 2007;16:359-64.
28. Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005;16:180-8.
29. Pontremoli R, Sofia A, Ravera M, Nicoletta C, Viazzi F, Tirotta A et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC study. Microalbuminuria: a Genoa investigation on complications. Hypertension 1997;30:1135-43.
30. Kaysen GA. Hyperlipidemia of the nephrotic syndrome. Kidney Int 1991;39(suppl 31):S8-15.
31. Jenkins AJ, Steel JS, Janus ED, Best JD. Increased plasma apoprotein(a) levels in IDDM patients with microalbuminuria. Diabetes 1991;40:787-90.
32. Fauvel JP, Hadj-Aissa A, Laville M, Fadat G, Labeeuw M, Zech P et al. Microalbuminuria in normotensives with genetic risk of hypertension. Nephron 1991;57:375-6.
33. Choi HS, Ryu SH, Lee KB. The relationship of microalbuminuria with metabolic syndrome. Nephron 2006;104:c85-93.
34. Gabriel R, Alonso M, Segura A, Tormo Mj, Artigao LM, Banegas JR et al. Prevalence and geographic variability of cardiovascular risk factors in Spain. Rev Esp Cardiol 2008;61:1030-40.
35. Robles NR, Mena C, Velasco J, Angulo E, Garrote T, Garcia Gallego F et al. Riesgo cardiovascular asociado a microalbuminuria en pacientes diabéticos y en pacientes con hipertensión arterial. Med Clin (Barc) 2008;130:206-9.
36. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakanjas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates and case fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612.
37. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third national health and nutrition examination survey. Am J Kidney Dis 2003;41:1-12.
38. Villar Alvarez F, Banegas Banegas JR, de Mata Donado Campos J, Rodriguez Artalejo F. Las enfermedades cardiovasculares y sus factores de riesgo en España: Hechos y Cifras. Informe SEA 2007. Fundación Astra Zeneca. Available at: http://www.searteriosclerosis.org. Accessed on 31 December 2010.